A PHASE II TRIAL OF BEVACIZUMAB COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH METASTATIC WELL-DIFFERENTIATED DUODENO-PANCREATIC ENDOCRINE TUMORS (BETTER STUDY)

被引：0
|
作者：
Seitz, J. [1 ]
Smith, D. [2 ]
O'Toole, D. [3 ]
Lepere, C. [4 ]
Dromain, C. [5 ]
Gorana, A. [6 ]
Mitry, E. [7 ]
Ducreux, M. P. [8 ]
机构：
[1] Hop Enfants La Timone, Marseille, France
[2] Hop St Andre, Bordeaux, France
[3] Hop Beaujon, Clichy, France
[4] Hop Europeen Georges Pompidou, Paris, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Labs Roche, Boulogne, France
[7] Inst Curie, Paris, France
[8] Inst Cancerol Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [31] A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
    Ducreux, M. P.
    Boige, V.
    Leboulleux, S.
    Malka, D.
    Kergoat, P.
    Dromain, C.
    Elias, D.
    de Baere, T.
    Sabourin, J. C.
    Duvillard, P.
    ONCOLOGY, 2006, 70 (02) : 134 - 140
  • [32] METNET: A Phase II Trial of Metformin in Patients with Well Differentiated Neuroendocrine Tumors
    Glasberg, J.
    Talans, A.
    Lopez, R.
    Recchimuzzi, D.
    Riechelmann, R.
    NEUROENDOCRINOLOGY, 2020, 110 : 226 - 226
  • [33] Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study
    Brizzi, M. P.
    Fazio, N.
    Ferrero, A.
    Nobili, E.
    Volante, M.
    Tozzi, L.
    D'Avolio, A.
    Milanesi, E.
    Dogliotti, L.
    Berruti, A.
    NEUROENDOCRINOLOGY, 2012, 96 : 22 - 23
  • [34] NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, George P.
    Oberg, Ann L.
    Foster, Nathan R.
    Sargent, Daniel J.
    Jaslowski, Anthony
    Campbell, Deborah
    Hedrick, Eric
    Grothey, Axel F.
    Alberts, Steve R.
    ANNALS OF ONCOLOGY, 2006, 17 : 310 - 310
  • [35] Dual immune checkpoint blockade in advanced well-differentiated neuroendocrine tumors, a phase II clinical trial.
    Scott, Susan Combs
    De Jesus-Acosta, Ana
    Hu, Chen
    Levy, Benjamin Philip
    Anagnostou, Valsamo
    Brahmer, Julie R.
    Illei, Peter Bela
    Jaffee, Elizabeth M.
    Marrone, Kristen
    Forde, Patrick M.
    Hann, Christine L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Long term clinical outcome of somatostatin analogues for treatment of progressive metastatic well-differentiated entero-pancreatic endocrine tumors (EP ETS)
    Panzuto, F
    Di Fonzo, M
    Nasoni, S
    Capurso, G
    Iannicelli, E
    Milione, M
    Sciuto, R
    Festa, A
    Corleto, VD
    Bordi, C
    Delle Fave, G
    GASTROENTEROLOGY, 2005, 128 (04) : A434 - A434
  • [37] NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma.
    Kim, G. P.
    Oberg, A.
    Kabat, B.
    Sing, A.
    Hedrick, E.
    Campbell, D.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 206S - 206S
  • [38] Phase 2 study of nab-sirolimus in patients with well-differentiated and advanced/metastatic neuroendocrine tumors of the gastrointestinal tract, lung, or pancreas
    Demeure, Michael J.
    Cohn, Allen Lee
    Seery, Tara Elisabeth
    Ding, Li
    Navarro, Willis H.
    Paulson, Andrew Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS601 - TPS601
  • [39] Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    Gao, Heli
    Dong, Jia
    Zhang, Wuhu
    Xu, Huaxiang
    Ye, Longyun
    Li, Hao
    Ni, Quanxing
    Wang, Wenquan
    Liu, Liang
    ENDOCRINE PRACTICE, 2022, 28 (03) : 292 - 297
  • [40] Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective study
    Elias, D
    Lasser, P
    Ducreux, M
    Duvillard, P
    Ouellet, JF
    Dromain, C
    Schlumberger, M
    Pocard, M
    Boige, V
    Miquel, C
    Baudin, E
    SURGERY, 2003, 133 (04) : 375 - 382
12345